In partnership with Precision VH, this webinar is a virtual panel discussion where experts will describe and debate the contributions that Medical Affairs can make to early R&D (preclinical through Ph-IIb).

Topics can include:

  • Anchoring R&D in a deep understanding of the disease and current approaches to treatment
  • Understanding the science behind the treatment
  • Identifying clinical, functional and economic endpoints relevant to value demonstration
  • Capturing the voice of the patient, caregiver and healthcare professionals
  • Augmenting investigator and site selection for clinical trials
  • Strategies to engage key stakeholders including patients and prescribers

In this webinar, you will learn how to:

1. Identify and explore additional value drivers for Medical Affairs in biopharma organizations

2. Build alignment towards common goals and initiate appropriate collaboration between Medical Affairs and R&D

Register Now